Relay Therapeutics Stock Price on December 20, 2024

RLAY Stock  USD 4.16  0.10  2.35%   
Below is the normalized historical share price chart for Relay Therapeutics extending back to July 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Relay Therapeutics stands at 4.16, as last reported on the 20th of December, with the highest price reaching 4.32 and the lowest price hitting 4.15 during the day.
IPO Date
16th of July 2020
200 Day MA
6.8414
50 Day MA
5.5102
Beta
1.675
 
Covid
If you're considering investing in Relay Stock, it is important to understand the factors that can impact its price. Relay Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.23, which implies the firm had a -0.23% return per unit of risk over the last 3 months. Relay Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Relay Therapeutics' Coefficient Of Variation of (453.58), variance of 13.3, and Risk Adjusted Performance of (0.17) to confirm the risk estimate we provide.
  
Stock Based Compensation is likely to rise to about 90.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 563.2 M in 2024. . Price To Sales Ratio is likely to drop to 50.19 in 2024. Price Earnings Ratio is likely to drop to -4.14 in 2024. Relay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2304

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRLAY

Estimated Market Risk

 3.64
  actual daily
32
68% of assets are more volatile

Expected Return

 -0.84
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Relay Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relay Therapeutics by adding Relay Therapeutics to a well-diversified portfolio.
Price Book
0.85
Enterprise Value Ebitda
(0.80)
Price Sales
71.2624
Shares Float
128.2 M
Wall Street Target Price
21.4546

Relay Therapeutics Valuation on December 20, 2024

It is possible to determine the worth of Relay Therapeutics on a given historical date. On December 20, 2024 Relay was worth 4.26 at the beginning of the trading date compared to the closed value of 4.16. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Relay Therapeutics stock. Still, in general, we apply an absolute valuation method to find Relay Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Relay Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Relay Therapeutics' related companies.
 Open High Low Close Volume
  4.20    4.32    4.12    4.26    1,966,872  
12/20/2024
  4.26    4.32    4.15    4.16    6,341,048  
Backtest Relay Therapeutics  |  Relay Therapeutics History  |  Relay Therapeutics Valuation   Previous
Open Value
4.26
4.16
Closing Value
15.17
Upside

Relay Therapeutics Trading Date Momentum on December 20, 2024

On December 20 2024 Relay Therapeutics was traded for  4.16  at the closing time. The top price for the day was 4.32  and the lowest listed price was  4.15 . The trading volume for the day was 6.3 M. The trading history from December 20, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.40% .

Relay Therapeutics Fundamentals Correlations and Trends

By evaluating Relay Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Relay financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Relay Therapeutics Stock history

Relay Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relay Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relay Therapeutics stock prices may prove useful in developing a viable investing in Relay Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding122.6 M69.5 M
Net Loss-261.5 M-274.5 M

Relay Therapeutics Quarterly Net Working Capital

659.23 Million

Relay Therapeutics Stock Technical Analysis

Relay Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Relay Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Relay Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Relay Therapeutics Period Price Range

Low
December 20, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Relay Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Relay Therapeutics December 20, 2024 Market Strength

Market strength indicators help investors to evaluate how Relay Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relay Therapeutics shares will generate the highest return on investment. By undertsting and applying Relay Therapeutics stock market strength indicators, traders can identify Relay Therapeutics entry and exit signals to maximize returns

Relay Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Relay Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Relay Stock Analysis

When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.